CPT® Code 87624

Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), high-risk types (eg, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68), pooled result

The CPT® Code 87624 refers to the detection of infectious agents through nucleic acid testing, specifically targeting high-risk types of Human Papillomavirus (HPV). HPV is a virus that can invade the skin and mucosal epithelia, leading to both clinical and subclinical infections. There are over 100 known types of HPV, with approximately 40 types affecting the anogenital region. Among these, certain high-risk oncogenic types, such as HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68, are often associated with high-grade squamous intraepithelial lesions (HSIL) and invasive cancers. In contrast, low-risk HPV types are linked to conditions such as acuminate condylomas and low-grade squamous intraepithelial lesions (LSIL) of the cervix. The detection of HPV through nucleic acid testing has become a standard practice in managing cervical disease in women. The procedure involves collecting exfoliated cervical cells using tools like a cytobrush or swab, which are then placed in a liquid transport medium. The sample undergoes treatment with sodium hydroxide to denature the DNA, followed by hybridization with specific RNA probes that identify both low-risk and high-risk HPV types. The resulting hybrids are analyzed using a luminometer to quantify the presence of high-risk HPV types, providing critical information for patient management and treatment decisions.